Your browser doesn't support javascript.
loading
Distinguishing atrial fibrillation from sinus rhythm using commercial pulse detection systems: The non-interventional BAYathlon study.
Müller, Christian; Hengstmann, Ulf; Fuchs, Michael; Kirchner, Martin; Kleinjung, Frank; Mathis, Harald; Martin, Stephan; Bläse, Ingo; Perings, Stefan.
Afiliación
  • Müller C; Bayer Vital GmbH, Leverkusen, Germany.
  • Hengstmann U; Bayer AG, Leverkusen, Germany.
  • Fuchs M; Fraunhofer-Institut für Angewandte Informationstechnik FIT, Sankt Augustin, Germany.
  • Kirchner M; Bayer Vital GmbH, Leverkusen, Germany.
  • Kleinjung F; Bayer AG, Berlin, Germany.
  • Mathis H; Fraunhofer-Institut für Angewandte Informationstechnik FIT, Sankt Augustin, Germany.
  • Martin S; Verbund Katholischer Kliniken Düsseldorf, Düsseldorf, Germany.
  • Bläse I; Cardio Centrum Düsseldorf, Düsseldorf, Germany.
  • Perings S; Cardio Centrum Düsseldorf, Düsseldorf, Germany.
Digit Health ; 7: 20552076211019620, 2021.
Article en En | MEDLINE | ID: mdl-34104466
ABSTRACT

OBJECTIVE:

Early diagnosis of atrial fibrillation (AFib) is a priority for stroke prevention. We sought to test four commercial pulse detection systems (CPDSs) for ability to distinguish AFib from normal sinus rhythm using a published algorithm (Zhou et al., PLoS One 2015;10e0136544), compared with visual diagnosis by electrocardiogram inspection.

METHODS:

BAYathlon was a prospective, non-interventional, single-centre study. Adult cardiology patients with documented AFib or sinus rhythm who were due to have a routine 5-min electrocardiogram were randomized to undergo a parallel 5-min pulse assessment with a Polar V800, eMotion Faros 360, TomTom heart rate monitor, or Adidas miCoach Smart Run.

RESULTS:

144 patients (73 with AFib, 71 with sinus rhythm (based on electrocardiograms); median age 73 years; 53.5% male) were analysed. Algorithm sensitivities (primary endpoint) and specificities for AFib when applied to CPDS recordings were 93.3% and 94.1% with the Polar V800, 90.0% and 84.2% with the eMotion Faros 360, and 0% and 100% with the other CPDSs (analysis period 127 heart rate signals + 2 min). When applied to routine electrocardiograms, the algorithm correctly detected AFib in 71/73 patients. Different analysis periods (127 heart rate signals +1 or 3 min) only slightly changed the sensitivities with the Polar V800 and eMotion Faros 360 and had no effect on the sensitivities with the other CPDSs.

CONCLUSION:

AFib screening using the applied algorithm is feasible with the Polar V800 and eMotion Faros 360 (which provide RR interval data) but not with the other CPDSs (which provide pre-processed heart rate time series).ClinicalTrials.gov identifier NCT02875106.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Screening_studies Idioma: En Revista: Digit Health Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Screening_studies Idioma: En Revista: Digit Health Año: 2021 Tipo del documento: Article País de afiliación: Alemania
...